Explore. Grow. Launch.
A resource for entrepreneurs and founders of in various stages of growth, WilmerHale Launch is your source for answers to the questions that impact you every day. We provide the tools and information you need to build your knowledge and position your for success.Start Exploring
Explore Topics Related to Your Business
New to the startup world or a seasoned entrepreneur in need of a refresher? Explore our formation topics to ensure your business is built for the long haul.Read More
Whether you’re flush with cash or in need of additional financing, understanding all of your financial options will set you up for the best chance of meeting your goals.Read More
Protecting your IP is critical to your company’s future. Ensuring you file necessary patents, obtain trademarks and secure copyright protection can be the difference between failure and success.Read More
Time to take your business to the next level? Increase your knowledge on what it will take to grow your business, whether in the US or abroad.Read More
Build Your Knowledge with Our Tools
This online tool built and operated by a third party helps founders make decisions on how to divide equity.Find Out More
Research News and Information
WilmerHale Advises ExecOnline in Securing $18 Million Series C Investment
On October 2, 2018, ExecOnline, a leader in delivering certificate-bearing leadership and development programs in partnership with elite business schools, announced it closed an $18 million Series C funding round led by ABS Capital Partners.Read More
MassBio Forum—Doing Business With China: Changing Regulatory Reforms and BD Opportunities in China
China is a torrid topic in today’s environment for emerging growth life science companies. With large markets and health care opportunities abounding both in China and in the United States, and with opportunities for MA-based life sciences companies to extend their own trajectories, understanding the landscape, horizons and nuances of the Chinese marketplace as well as predilections of Chinese investors and strategic partners, is critically important. This forum will present an overview of the rapidly changing regulatory and market landscape in China. Key topics include: Overview of the landscape today and future outlook Emergence of innovative Chinese pharmaceutical companies Leveraging China to accelerate clinical development path Protection of IP in China: Legal concerns and practical solutions Impact of regulations on currency, taxes, material import/export, etc. Departures from the norm: Joint ventures, strategic partnerships and global licensing WilmerHale Partner Kenneth Zhou will be a speaker on this panel along with Kate Haviland, CBO of Blueprint Medicines, and Wei Zhao, VP of 6 Dimensions (formerly Wuxi Ventures). Helen Ho, Vice President and Head of Corporate Development at Blueprint Medicines will moderate.Read More
Watch WilmerHale lawyers and industry experts speak about topics pertaining to your business.